510(k) Report

FDA applicant

Alere Technologies AS

Oslo, NO3 decisions2015–20181 recall

FDA records 3 decisions for Alere Technologies AS (Oslo, NO) from 2015 to 2018: 3 510(k) clearances. Most are in product codes PDJ (Hemoglobin A1c Test System) and LCP (Assay, Glycosylated Hemoglobin). Its devices cite 4 predicates, 1 of them its own earlier devices. 1 recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided Alere Technologies AS’s devices, and how often a recall has named them.

FDA decisions per year

2in 2018

2015: 12018: 2
2015high 2 (2018) · low 0 (2016)2026

2026 so far, outlined.

Recalls per year

1in 2020

2020: 1
2015high 1 (2020) · low 0 (2015)2026

Class I Class II/III not classified

FIG. 1 — Alere Technologies AS by year, 2015–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Alere Technologies AS’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Alere”

FDA records each applicant name separately; these may or may not be the same firm.